HEN.DE vs. MRNA
HEN.DE (Henkel AG & Co. KGaA) and MRNA (Moderna, Inc.) are both stocks. HEN.DE operates in Household & Personal Products (Consumer Defensive), while MRNA operates in Biotechnology (Healthcare). Over the past 5 years, HEN.DE returned -2.83%/yr vs -23.49%/yr for MRNA. At a 0.04 correlation, their price movements are largely independent.
Performance
HEN.DE vs. MRNA - Performance Comparison
Loading charts...
Different Trading Currencies
HEN.DE is traded in EUR, while MRNA is traded in USD. To make them comparable, the MRNA values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, HEN.DE achieves a -3.12% return, which is significantly lower than MRNA's 76.93% return.
HEN.DE
- 1D
- -0.65%
- 1M
- 4.20%
- YTD
- -3.12%
- 6M
- -2.36%
- 1Y
- -2.29%
- 3Y*
- -0.11%
- 5Y*
- -2.83%
- 10Y*
- -1.48%
MRNA
- 1D
- 5.01%
- 1M
- 11.18%
- YTD
- 76.93%
- 6M
- 102.94%
- 1Y
- 86.01%
- 3Y*
- -28.26%
- 5Y*
- -23.49%
- 10Y*
- —
HEN.DE vs. MRNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
HEN.DE Henkel AG & Co. KGaA | -3.12% | -9.72% | 17.71% | 10.83% | -9.55% | -10.96% | -1.23% | 0.16% | -4.24% |
MRNA Moderna, Inc. | 76.93% | -37.49% | -55.43% | -46.29% | -24.89% | 161.30% | 390.08% | 30.99% | -18.38% |
Correlation
The correlation between HEN.DE and MRNA is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.04 |
Correlation (All Time) Calculated using the full available price history since Dec 10, 2018 | 0.04 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HEN.DE vs. MRNA — Risk / Return Rank
HEN.DE
MRNA
HEN.DE vs. MRNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Henkel AG & Co. KGaA (HEN.DE) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HEN.DE | MRNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.49 | ||
| Sortino ratioReturn per unit of downside risk | -2.28 | ||
| Omega ratioGain probability vs. loss probability | 0.99 | 1.25 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | -0.10 | 2.53 | -2.63 |
| Martin ratioReturn relative to average drawdown | -0.23 | 4.92 | -5.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HEN.DE | MRNA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.13 | 1.36 | -1.49 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.15 | -0.36 | +0.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.07 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | 0.20 | +0.10 |
Drawdowns
HEN.DE vs. MRNA - Drawdown Comparison
The maximum HEN.DE drawdown since its inception was -55.97%, smaller than the maximum MRNA drawdown of -95.30%. Use the drawdown chart below to compare losses from any high point for HEN.DE and MRNA.
Loading charts...
Drawdown Indicators
| HEN.DE | MRNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.97% | -95.30% | +39.33% |
Max Drawdown (1Y)Largest decline over 1 year | -22.35% | -34.16% | +11.81% |
Max Drawdown (3Y)Largest decline over 3 years | -22.75% | -87.37% | +64.62% |
Max Drawdown (5Y)Largest decline over 5 years | -28.55% | -95.30% | +66.75% |
Max Drawdown (10Y)Largest decline over 10 years | -49.66% | — | — |
Current DrawdownCurrent decline from peak | -30.22% | -89.24% | +59.02% |
Average DrawdownAverage peak-to-trough decline | -17.52% | -55.69% | +38.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.79% | 17.56% | -7.77% |
Volatility
HEN.DE vs. MRNA - Volatility Comparison
The current volatility for Henkel AG & Co. KGaA (HEN.DE) is 6.54%, while Moderna, Inc. (MRNA) has a volatility of 18.02%. This indicates that HEN.DE experiences smaller price fluctuations and is considered to be less risky than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HEN.DE | MRNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.54% | 18.02% | -11.48% |
Volatility (6M)Calculated over the trailing 6-month period | 15.13% | 47.67% | -32.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.94% | 63.41% | -45.47% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.40% | 65.62% | -47.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.79% | 71.39% | -51.60% |
Dividends
HEN.DE vs. MRNA - Dividend Comparison
HEN.DE's dividend yield for the trailing twelve months is around 3.37%, while MRNA has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HEN.DE Henkel AG & Co. KGaA | 3.37% | 3.11% | 2.46% | 2.82% | 3.04% | 2.66% | 4.64% | 2.18% | 2.06% | 1.60% | 1.46% | 1.46% |
MRNA Moderna, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
HEN.DE vs. MRNA - Financials Comparison
This section allows you to compare key financial metrics between Henkel AG & Co. KGaA and Moderna, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
HEN.DE and MRNA have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for HEN.DE and MRNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer